NeuroOne officer granted 12,500 stock options

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) reported that officer Mark Christianson received a grant of 12,500 options to purchase common stock.

Rhea-AI Filing Summary

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) reported that officer Mark Christianson received a grant of 12,500 options to purchase common stock. The options have an exercise price of $1.77 per share and expire on August 27, 2036. According to the vesting terms, 25% of the options vest on August 28, 2027, with the remaining 75% vesting in 12 equal quarterly installments thereafter. Following this award, Christianson directly holds 12,500 derivative securities related to NMTC common stock.

Insider Trade Summary

Grant/Award: 12,500 shares

Grant/Award 1 txn

Insider Christianson Mark

Role Market Development Director

Type	Security	Shares	Price	Value
Grant/Award	Option to Purchase Common Stock F1	12,500	$0.00	$0.00

Holdings After Transaction: Option to Purchase Common Stock — 12,500 contracts (Direct)

Footnotes (1)

1. F1. 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.

Key Figures

Options granted: 12,500 options Exercise price: $1.77 per share Expiration date: August 27, 2036 +4 more

7 metrics

Options granted 12,500 options Grant of options to purchase NMTC common stock to Mark Christianson

Exercise price $1.77 per share Exercise price of the options to purchase NMTC common stock

Expiration date August 27, 2036 Expiration date of the granted stock options

Vesting cliff portion 25% Portion of options vesting on August 28, 2027

Remainder vesting 75% Remaining options vesting in 12 equal quarterly installments

Options underlying shares 12,500 shares Number of common shares underlying the option grant

Post-transaction derivative holdings 12,500 derivative securities Total options held directly by Mark Christianson after the grant

Key Terms

Option to Purchase Common Stock, exercise price, vesting, derivative securities

4 terms

Option to Purchase Common Stock financial

"security_title is reported as "Option to Purchase Common Stock""

exercise price financial

"The options have an exercise price of $1.77 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"25% will vest on August 28, 2027, and the remaining 75% will vest"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

derivative securities financial

"Christianson directly holds 12,500 derivative securities related to common stock"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did NMTC disclose about Mark Christianson’s latest equity award?

NMTC disclosed that Mark Christianson received a grant of 12,500 options to purchase NMTC common stock at an exercise price of $1.77 per share, expiring on August 27, 2036, as part of his compensation.

What is the vesting schedule of Mark Christianson’s new NMTC stock options?

The filing states that 25% of the options vest on August 28, 2027, and the remaining 75% vest in 12 equal quarterly installments thereafter, creating a multi-year vesting period tied to continued service.

What is the exercise price of the new NMTC options granted to Mark Christianson?

The options granted to Mark Christianson have an exercise price of $1.77 per share, meaning he can purchase NMTC common stock at that price once the options vest and before they expire on August 27, 2036.

How many NMTC derivative securities does Mark Christianson hold after this transaction?

After this transaction, Mark Christianson is reported to directly hold 12,500 derivative securities in the form of options to purchase NMTC common stock, all from this newly granted award.

Is Mark Christianson’s NMTC option grant a purchase or a sale of stock?

The transaction is reported as a grant or award acquisition of options, not a market purchase or sale of stock. It reflects compensation in the form of stock options rather than an open-market trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 05:01 PM EDT Accepted by SEC EDGAR 08/28/2026 - 05:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Christianson Mark

(Last) (First) (Middle)

7599 ANAGRAM DR.

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NEUROONE MEDICAL TECHNOLOGIES Corp [ NMTC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Market Development Director

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$1.77	08/28/2026		A		12,500		(1)	08/27/2036	Common Stock	12,500	$0	12,500	D

Explanation of Responses:

1. 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.

	/s/ Emily Johns, by Power of Attorney	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)